Matthews (2022)

Myocardial infarction

Cardiology • Registry Data • Sweden

Study Metrics
Total Sample 18222
Treatment Group 3462
Control Group 14760
Covariates 24
PICO Comparisons 2
Quality Indicators
Transparency High
DAG Usage No
QBA Performed No

Study Information

First Author: Matthews
Publication Year: 2022
DOI: https://doi.org/10.1093/aje/kwac098
Preprint: No preprint

Institution & Funding

Institution Type: Academic
Institutions: Karolinska Institutet, Harvard T.H. Chan School of Public Health, Örebro University Hospital, Uppsala University, Danderyd University Hospital-Karolinska Institutet
Funding: Declared: Public, research institute, NGO
Funding Institutions: This work was supported by a grant from the Swedish Research Council (2018-03028). A.A.M. received funds from the Strategic Research Program in Epidemiology at Karolinska Institutet, Forte (2020-00029), and Swedish Research Council (2021-02236). I.J.D. received funds from the Patient-Centered Outcomes Research Institute (PCORI; ME-1502-27794) during the conduct of the study.

Study Context

Disease: Myocardial infarction
Disease Category: Cardiology
Data Type: Registry
Number of Data Sources: 1
Geography: Sweden
Eligible Sample: 18222.0
Number of Treatments: 2

Analytical Methods

Missing Data Method: Complete case
Matching Method: Not defined
Analysis Method: Cox PH
Estimand: PP

Quality Methods

Directed Acyclic Graph (DAG) Not Used
Quantitative Bias Analysis (QBA) Not Performed

Target Trial Information

Target Trial Name: TASTE
Registration Number: NCT01093404
Target Trial DOI: https://doi.org/10.1056/NEJMoa1308789, https://doi.org/10.1056/NEJMoa1405707

TTE vs RCT Comparisons

Detailed comparison between Target Trial Emulation results and corresponding Randomized Controlled Trial outcomes.

Death
TASTE
RR Efficacy
Population

Adults (≥18 years) with ST-elevation myocardial infarction (STEMI) requiring percutaneous coronary intervention (PCI)

Intervention

Thrombus aspiration followed by PCI

Comparison

PCI without thrombus aspiration

Outcome

Death

RCT Result

0.94

95% CI: [0.78, 1.15]


vs
TTE Result

1.09

95% CI: [0.96, 1.24]

Concordance Assessment
Confidence Interval Overlap: Yes
CIs overlap, suggesting concordance
Direction Agreement: Different Direction
Different conclusions
Myocardial infarction
TASTE
RR Efficacy
Population

Adults (≥18 years) with ST-elevation myocardial infarction (STEMI) requiring percutaneous coronary intervention (PCI)

Intervention

Thrombus aspiration followed by PCI

Comparison

PCI without thrombus aspiration

Outcome

Myocardial infarction

RCT Result

0.97

95% CI: [0.73, 1.28]


vs
TTE Result

0.96

95% CI: [0.79, 1.17]

Concordance Assessment
Confidence Interval Overlap: Yes
CIs overlap, suggesting concordance
Direction Agreement: Same Direction
Both point to similar conclusion

Transparency Indicators

Protocol Registration Available
Data Sharing Not Available
Code Sharing Available
Overall Transparency Score:
High Transparency - This study meets good transparency standards.

Conflicts & Funding

Conflicts of Interest: Declared: Financial
COI Institutions: Sanofi Pasteur, Cytel, ProPublica
Funding Source: Declared: Public, research institute, NGO
Funding Institutions: This work was supported by a grant from the Swedish Research Council (2018-03028). A.A.M. received funds from the Strategic Research Program in Epidemiology at Karolinska Institutet, Forte (2020-00029), and Swedish Research Council (2021-02236). I.J.D. received funds from the Patient-Centered Outcomes Research Institute (PCORI; ME-1502-27794) during the conduct of the study.